Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02480 LUZHU BIOTECH-B
RT Nominal up22.000 +0.900 (+4.265%)
Ranking Overview
Buy
Ranking based on 1 research report(s)
Average Ranking 2.00
0
1
0
0
0
Previous Financial Performance
Financial Year 12/2024 EPS -83.00 RMB (cts)
Net Profit -168.24 RMB (MIL) DPS 0.00 RMB (cts)
Consolidation Estimation
Financial Year Profit / (Loss)
(RMB (MIL))
EPS/
((LPS)(RMB (cts))
DPS
(RMB (cts))
Net Asset Value per Share
(RMB)
Highest
(RMB (MIL))
Lowest
(RMB (MIL))
2025-177.00-88.00---177.00-177.00
202688.0044.00--88.0088.00
2027202.00100.00--202.00202.00
Profit Estimation
Profit Estimation Profit / (Loss)
(RMB (MIL))
EPS*/
(LPS) (RMB (cts))
DPS *
(RMB (cts))
Broker Ranking Target Price*
(HKD)
Update Date
2025-177.00-88.00--CITIC SECBuy31.00 24/04/2025
 
202688.0044.00--CITIC SEC----24/04/2025
 
2027202.00100.00--CITIC SEC----24/04/2025
Remarks:  Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa.
  *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue
  Real time quote last updated: 24/07/2025 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service